IN8bio, Inc.

MUN:6JH Stock Report

Market Cap: €35.5m

IN8bio Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Will Ho

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage19.5%
CEO tenure7yrs
CEO ownership10.4%
Management average tenure1.8yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Will Ho's remuneration changed compared to IN8bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$21m

Mar 31 2022n/an/a

-US$18m

Dec 31 2021US$2mUS$446k

-US$15m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$1mUS$279k

-US$10m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$214kUS$214k

-US$6m

Compensation vs Market: Will's total compensation ($USD2.29M) is above average for companies of similar size in the German market ($USD417.54K).

Compensation vs Earnings: Will's compensation has increased whilst the company is unprofitable.

CEO

Will Ho (45 yo)

7yrs

Tenure

US$2,291,689

Compensation

Mr. William Ho, also known as Will, is the Co-Founder of IN8bio, Inc. and has been President, Chief Executive Officer and Director since November 2015 and had been its Chief Financial Officer since October...

Leadership Team

NamePositionTenureCompensationOwnership
William Ho
Co-Founder7yrsUS$2.29m10.37%
€ 3.7m
Lawrence Lamb
Executive VP4yrsUS$918.75k0.41%
€ 144.7k
Patrick McCall
CFO & Secretary1.7yrsUS$1.55m0.021%
€ 7.6k
Kate Rochlin
Chief Operating Officer1.9yrsno data0.021%
€ 7.6k
Trishna Goswami
Chief Medical Officerless than a yearno data0.011%
€ 3.8k
Kenneth LaMontagne
Senior Vice President of Business Developmentless than a yearno datano data

1.8yrs

Average Tenure

43yo

Average Age

Experienced Management: 6JH's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
William Ho
Co-Founder7yrsUS$2.29m10.37%
€ 3.7m
Peter Brandt
Independent Director3.3yrsUS$100.44k1.17%
€ 417.4k
Alan Roemer
Independent Chairman of the Board2.2yrsUS$522.05k0.23%
€ 81.2k
Emily Fairbairn
Independent Director1.3yrsUS$165.43k17.27%
€ 6.1m
Marcela Maus
Member of Scientific Advisory Boardno datano datano data
Travis Whitfill
Independent Director2.2yrsUS$96.43k0%
€ 0
Luba Greenwood
Independent Director1.3yrsUS$103.02k0.032%
€ 11.4k
Bruce Levine
Member of Scientific Advisory Boardno datano datano data
Siraj Ali
Member of Scientific Advisory Boardno datano datano data
Bianca Santomasso
Member of Scientific Advisory Boardno datano datano data
Dieter Kabelitz
Member of Scientific Advisory boardno datano datano data
Michael Bishop
Member of Scientific Advisory Boardless than a yearno datano data

2.2yrs

Average Tenure

45yo

Average Age

Experienced Board: 6JH's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/29 21:03
End of Day Share Price 2022/09/01 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IN8bio, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
Swayampakula RamakanthH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC